Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Clasificación en acciones #375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Precio por acción
$40.45
Capitalización bursátil
$64.36B
Cambio (1 día)
1.19%
Cambio (1 año)
43.11%
País
JP
Comercio Takeda Pharmaceutical Company Limited (4502)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Takeda Pharmaceutical Company Limited (4502)
La acción Takeda Pharmaceutical Company Limited (símbolo: 4502) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 22, 2026.
Una acción 4502 comprada antes de Oct 22, 2026 equivaldría hoy a 0 acciones 4502.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
0 -
DE
0 -
DE
0 -
CH
5 x119
IN
0 -
CN